Temporal trends in Enterobacter species bloodstream infection: a populationabased study from 1998a2007

Enterobacter species are the fourth most common cause of Gram-negative bloodstream infection (BSI). We examined temporal changes and seasonal variation in the incidence rate of Enterobacter spp. BSI, estimated 28-day and 1-year mortality, and determined in vitro antimicrobial resistance rates of Ent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2011-04, Vol.17 (4), p.539-545
Hauptverfasser: AlaHasan, M N, Lahr, B D, EckelaPassow, JE, Baddour, L M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 545
container_issue 4
container_start_page 539
container_title Clinical microbiology and infection
container_volume 17
creator AlaHasan, M N
Lahr, B D
EckelaPassow, JE
Baddour, L M
description Enterobacter species are the fourth most common cause of Gram-negative bloodstream infection (BSI). We examined temporal changes and seasonal variation in the incidence rate of Enterobacter spp. BSI, estimated 28-day and 1-year mortality, and determined in vitro antimicrobial resistance rates of Enterobacter spp. bloodstream isolates in Olmsted County, Minnesota, from 1 January 1998 to 31 December 2007. Multivariable Poisson regression was used to examine temporal changes and seasonal variation in incidence rate and Kaplan-Meier method was used to estimate 28-day and 1-year mortality. The median age of patients with Enterobacter spp. BSI was 58years and 53% were female. The overall age- and gender-adjusted incidence rate of Enterobacter spp. BSI was 3.3 per 100000 person-years (95% CI 2.3-4.4). There was a linear trend of increasing incidence rate from 0.8 (95% CI 0-1.9) to 6.2 (95% CI 3.0-9.3) per 100000 person-years between 1998 and 2007 (p0.002). There was no significant difference in the incidence rate of Enterobacter spp. BSI during the warmest 4months compared to the remainder of the year (incidence rate ratio 1.06; 95% CI 0.47-2.01). The overall 28-day and 1-year mortality rates of Enterobacter spp. BSI were 21% (95% CI 8-34%) and 38% (95% CI 22-53%), respectively. Up to 13% of Enterobacter spp. bloodstream isolates were resistant to third-generation cephalosporins. To our knowledge, this is the first population-based study to describe the epidemiology and outcome of Enterobacter spp. BSI. The increase in incidence rate of Enterobacter spp. BSI over the past decade, coupled with its associated antimicrobial resistance, dictate the need for further investigation of this syndrome.Original Abstract: Clin Microbiol Infect 2011; 17: 539-545
doi_str_mv 10.1111/j.1469-0691.2010.03277.x
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_888106880</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>888106880</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_8881068803</originalsourceid><addsrcrecordid>eNqNis1KxDAUhYMoOI7zDnfnqvWmKW3iVkZ8gFm4G9L2FjqkSSY3BX17I4hrz-b8fUKAxFoWPV9q2Xamws7IusGyomr6vv68Ebu_47ZkaXTVt-rjXjwwXxCxUardiflEawzJOsiJ_MSweDj6TCkMdiwGHGlciGFwIUxcILsWZqYxL8G_gIUY4ubsT7ODZZqA8zZ9wZzCCtIYbRvE_lHczdYxHX59L57ejqfX9yqmcN2I83ldeCTnrKew8VlrLbHTGtX_yW9lcVKh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>888106880</pqid></control><display><type>article</type><title>Temporal trends in Enterobacter species bloodstream infection: a populationabased study from 1998a2007</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>AlaHasan, M N ; Lahr, B D ; EckelaPassow, JE ; Baddour, L M</creator><creatorcontrib>AlaHasan, M N ; Lahr, B D ; EckelaPassow, JE ; Baddour, L M</creatorcontrib><description>Enterobacter species are the fourth most common cause of Gram-negative bloodstream infection (BSI). We examined temporal changes and seasonal variation in the incidence rate of Enterobacter spp. BSI, estimated 28-day and 1-year mortality, and determined in vitro antimicrobial resistance rates of Enterobacter spp. bloodstream isolates in Olmsted County, Minnesota, from 1 January 1998 to 31 December 2007. Multivariable Poisson regression was used to examine temporal changes and seasonal variation in incidence rate and Kaplan-Meier method was used to estimate 28-day and 1-year mortality. The median age of patients with Enterobacter spp. BSI was 58years and 53% were female. The overall age- and gender-adjusted incidence rate of Enterobacter spp. BSI was 3.3 per 100000 person-years (95% CI 2.3-4.4). There was a linear trend of increasing incidence rate from 0.8 (95% CI 0-1.9) to 6.2 (95% CI 3.0-9.3) per 100000 person-years between 1998 and 2007 (p0.002). There was no significant difference in the incidence rate of Enterobacter spp. BSI during the warmest 4months compared to the remainder of the year (incidence rate ratio 1.06; 95% CI 0.47-2.01). The overall 28-day and 1-year mortality rates of Enterobacter spp. BSI were 21% (95% CI 8-34%) and 38% (95% CI 22-53%), respectively. Up to 13% of Enterobacter spp. bloodstream isolates were resistant to third-generation cephalosporins. To our knowledge, this is the first population-based study to describe the epidemiology and outcome of Enterobacter spp. BSI. The increase in incidence rate of Enterobacter spp. BSI over the past decade, coupled with its associated antimicrobial resistance, dictate the need for further investigation of this syndrome.Original Abstract: Clin Microbiol Infect 2011; 17: 539-545</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/j.1469-0691.2010.03277.x</identifier><language>eng</language><subject>Age ; Cephalosporins ; Drug resistance ; Enterobacter ; Epidemiology ; Infection ; Mortality ; Population studies ; Seasonal variations</subject><ispartof>Clinical microbiology and infection, 2011-04, Vol.17 (4), p.539-545</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>AlaHasan, M N</creatorcontrib><creatorcontrib>Lahr, B D</creatorcontrib><creatorcontrib>EckelaPassow, JE</creatorcontrib><creatorcontrib>Baddour, L M</creatorcontrib><title>Temporal trends in Enterobacter species bloodstream infection: a populationabased study from 1998a2007</title><title>Clinical microbiology and infection</title><description>Enterobacter species are the fourth most common cause of Gram-negative bloodstream infection (BSI). We examined temporal changes and seasonal variation in the incidence rate of Enterobacter spp. BSI, estimated 28-day and 1-year mortality, and determined in vitro antimicrobial resistance rates of Enterobacter spp. bloodstream isolates in Olmsted County, Minnesota, from 1 January 1998 to 31 December 2007. Multivariable Poisson regression was used to examine temporal changes and seasonal variation in incidence rate and Kaplan-Meier method was used to estimate 28-day and 1-year mortality. The median age of patients with Enterobacter spp. BSI was 58years and 53% were female. The overall age- and gender-adjusted incidence rate of Enterobacter spp. BSI was 3.3 per 100000 person-years (95% CI 2.3-4.4). There was a linear trend of increasing incidence rate from 0.8 (95% CI 0-1.9) to 6.2 (95% CI 3.0-9.3) per 100000 person-years between 1998 and 2007 (p0.002). There was no significant difference in the incidence rate of Enterobacter spp. BSI during the warmest 4months compared to the remainder of the year (incidence rate ratio 1.06; 95% CI 0.47-2.01). The overall 28-day and 1-year mortality rates of Enterobacter spp. BSI were 21% (95% CI 8-34%) and 38% (95% CI 22-53%), respectively. Up to 13% of Enterobacter spp. bloodstream isolates were resistant to third-generation cephalosporins. To our knowledge, this is the first population-based study to describe the epidemiology and outcome of Enterobacter spp. BSI. The increase in incidence rate of Enterobacter spp. BSI over the past decade, coupled with its associated antimicrobial resistance, dictate the need for further investigation of this syndrome.Original Abstract: Clin Microbiol Infect 2011; 17: 539-545</description><subject>Age</subject><subject>Cephalosporins</subject><subject>Drug resistance</subject><subject>Enterobacter</subject><subject>Epidemiology</subject><subject>Infection</subject><subject>Mortality</subject><subject>Population studies</subject><subject>Seasonal variations</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNis1KxDAUhYMoOI7zDnfnqvWmKW3iVkZ8gFm4G9L2FjqkSSY3BX17I4hrz-b8fUKAxFoWPV9q2Xamws7IusGyomr6vv68Ebu_47ZkaXTVt-rjXjwwXxCxUardiflEawzJOsiJ_MSweDj6TCkMdiwGHGlciGFwIUxcILsWZqYxL8G_gIUY4ubsT7ODZZqA8zZ9wZzCCtIYbRvE_lHczdYxHX59L57ejqfX9yqmcN2I83ldeCTnrKew8VlrLbHTGtX_yW9lcVKh</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>AlaHasan, M N</creator><creator>Lahr, B D</creator><creator>EckelaPassow, JE</creator><creator>Baddour, L M</creator><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20110401</creationdate><title>Temporal trends in Enterobacter species bloodstream infection: a populationabased study from 1998a2007</title><author>AlaHasan, M N ; Lahr, B D ; EckelaPassow, JE ; Baddour, L M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_8881068803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Age</topic><topic>Cephalosporins</topic><topic>Drug resistance</topic><topic>Enterobacter</topic><topic>Epidemiology</topic><topic>Infection</topic><topic>Mortality</topic><topic>Population studies</topic><topic>Seasonal variations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AlaHasan, M N</creatorcontrib><creatorcontrib>Lahr, B D</creatorcontrib><creatorcontrib>EckelaPassow, JE</creatorcontrib><creatorcontrib>Baddour, L M</creatorcontrib><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AlaHasan, M N</au><au>Lahr, B D</au><au>EckelaPassow, JE</au><au>Baddour, L M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Temporal trends in Enterobacter species bloodstream infection: a populationabased study from 1998a2007</atitle><jtitle>Clinical microbiology and infection</jtitle><date>2011-04-01</date><risdate>2011</risdate><volume>17</volume><issue>4</issue><spage>539</spage><epage>545</epage><pages>539-545</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>Enterobacter species are the fourth most common cause of Gram-negative bloodstream infection (BSI). We examined temporal changes and seasonal variation in the incidence rate of Enterobacter spp. BSI, estimated 28-day and 1-year mortality, and determined in vitro antimicrobial resistance rates of Enterobacter spp. bloodstream isolates in Olmsted County, Minnesota, from 1 January 1998 to 31 December 2007. Multivariable Poisson regression was used to examine temporal changes and seasonal variation in incidence rate and Kaplan-Meier method was used to estimate 28-day and 1-year mortality. The median age of patients with Enterobacter spp. BSI was 58years and 53% were female. The overall age- and gender-adjusted incidence rate of Enterobacter spp. BSI was 3.3 per 100000 person-years (95% CI 2.3-4.4). There was a linear trend of increasing incidence rate from 0.8 (95% CI 0-1.9) to 6.2 (95% CI 3.0-9.3) per 100000 person-years between 1998 and 2007 (p0.002). There was no significant difference in the incidence rate of Enterobacter spp. BSI during the warmest 4months compared to the remainder of the year (incidence rate ratio 1.06; 95% CI 0.47-2.01). The overall 28-day and 1-year mortality rates of Enterobacter spp. BSI were 21% (95% CI 8-34%) and 38% (95% CI 22-53%), respectively. Up to 13% of Enterobacter spp. bloodstream isolates were resistant to third-generation cephalosporins. To our knowledge, this is the first population-based study to describe the epidemiology and outcome of Enterobacter spp. BSI. The increase in incidence rate of Enterobacter spp. BSI over the past decade, coupled with its associated antimicrobial resistance, dictate the need for further investigation of this syndrome.Original Abstract: Clin Microbiol Infect 2011; 17: 539-545</abstract><doi>10.1111/j.1469-0691.2010.03277.x</doi></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2011-04, Vol.17 (4), p.539-545
issn 1198-743X
1469-0691
language eng
recordid cdi_proquest_miscellaneous_888106880
source Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Age
Cephalosporins
Drug resistance
Enterobacter
Epidemiology
Infection
Mortality
Population studies
Seasonal variations
title Temporal trends in Enterobacter species bloodstream infection: a populationabased study from 1998a2007
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A05%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Temporal%20trends%20in%20Enterobacter%20species%20bloodstream%20infection:%20a%20populationabased%20study%20from%201998a2007&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=AlaHasan,%20M%20N&rft.date=2011-04-01&rft.volume=17&rft.issue=4&rft.spage=539&rft.epage=545&rft.pages=539-545&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/j.1469-0691.2010.03277.x&rft_dat=%3Cproquest%3E888106880%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=888106880&rft_id=info:pmid/&rfr_iscdi=true